Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer.

The 11-kD protease (PR) encoded by the human immunodeficiency virus 1 (HIV-1) is essential for the correct processing of viral polyproteins and the maturation of infectious virus, and is therefore a target for the design of selective acquired immunodeficiency syndrome (AIDS) therapeutics. To facilitate the identification of novel inhibitors of HIV-1 PR, as well as to permit detailed studies on the enzymology and inhibition of this enzyme, a continuous assay for its activity was developed that was based on intramolecular fluorescence resonance energy transfer (RET). The assay used the quenched fluorogenic substrate 4-(4-dimethylaminophenylazo)benzoic acid (DABCYL)--Ser Gln Asn Tyr Pro Ile Val Gln--5-[(2-aminoethyl)amino]naphthalene-1 sulfonic acid (EDANS), whose peptide sequence is derived from a natural processing site for HIV-1 PR. Incubation of recombinant HIV-1 PR with the fluorogenic substrate resulted in specific cleavage at the Tyr-Pro bond and a time-dependent increase in fluorescence intensity that was linearly related to the extent of substrate hydrolysis. An internally quenched fluorogenic substrate was also designed that was selectively cleaved by the related PR from avian myeloblastosis virus (AMV). The fluorescence quantum yields of the HIV-1 PR and AMV PR substrates in the RET assay increased by 40.0- and 34.4-fold, respectively, per mole of substrate cleaved. Because of its simplicity, rapidity, and precision in the determination of reaction rates required for kinetic analysis, this method offers many advantages over the commonly used high-performance liquid chromatography- or electrophoresis-based assays for peptide substrate hydrolysis by retroviral PRs.

[1]  E. Katchalski,et al.  Use of substrates with fluorescent donor and acceptor chromophores for the kinetic assay of hydrolases , 1973, FEBS letters.

[2]  T. Copeland,et al.  Primary structure and processing of gag and env gene products of human T-cell leukemia viruses HTLV-ICR and HTLV-IATK. , 1985, Current topics in microbiology and immunology.

[3]  E. Wimmer,et al.  Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Maria Miller,et al.  Crystal structure of a retroviral protease proves relationship to aspartic protease family , 1989, Nature.

[5]  A. Cornish-Bowden.  A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. , 1974, The Biochemical journal.

[6]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[7]  R. Dixon,et al.  Human immunodeficiency virus protease. Bacterial expression and characterization of the purified aspartic protease. , 1989, The Journal of biological chemistry.

[8]  V. Turk,et al.  Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Skalka,et al.  Synthetic peptides as substrates and inhibitors of a retroviral protease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[10]  M. Jaskólski,et al.  Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. , 1989, Science.

[11]  William R. Taylor,et al.  A structural model for the retroviral proteases , 1987, Nature.

[12]  B. Dunn,et al.  A new substrate for porcine pepsin possessing cryptic fluorescence properties. , 1983, Analytical biochemistry.

[13]  M. Navia,et al.  Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1 , 1989, Nature.

[14]  D. Veber,et al.  HIV-1 protease specificity of peptide cleavage is sufficient for processing of gag and pol polyproteins. , 1988, Biochemical and biophysical research communications.

[15]  V. Kostka,et al.  Chromophoric and fluorophoric peptide substrates cleaved through the dipeptidyl carboxypeptidase activity of cathepsin B. , 1987, Analytical Biochemistry.

[16]  T. Yasunaga,et al.  Inhibition of retroviral protease activity by an aspartyl proteinase inhibitor , 1987, Nature.

[17]  A. Bernstein,et al.  RNA tumor viruses , 1982 .

[18]  E. Katchalski‐Katzir,et al.  Brownian motion of the ends of oligopeptide chains in solution as estimated by energy transfer between the chain ends , 1978 .

[19]  C. Debouck,et al.  Peptide substrates and inhibitors of the HIV-1 protease. , 1989, Biochemical and biophysical research communications.

[20]  I. Boros,et al.  In vivo and in vitro autoprocessing of human immunodeficiency virus protease expressed in Escherichia coli. , 1988, The Journal of biological chemistry.

[21]  J. Powers,et al.  Pseudomonas aeruginosa elastase. Development of a new substrate, inhibitors, and an affinity ligand. , 1980, Journal of Biological Chemistry.

[22]  B. Vallee,et al.  Fluorescende determination of carboxypeptidase A activity based on electronic energy transfer. , 1972, Analytical biochemistry.

[23]  B. Dunn,et al.  Effective blocking of HIV‐1 proteinase activity by characteristic inhibitors of aspartic proteinases , 1989, FEBS letters.

[24]  E. Katchalski‐Katzir,et al.  Intramolecularly quenched fluorogenic substrates for hydrolytic enzymes. , 1979, Analytical biochemistry.

[25]  L. Stryer.  Fluorescence energy transfer as a spectroscopic ruler. , 1978, Annual review of biochemistry.

[26]  C. Cantor,et al.  The use of singlet-singlet energy transfer to study macromolecular assemblies. , 1978, Methods in enzymology.

[27]  S. Goff,et al.  A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins , 1985, Journal of virology.

[28]  J. Louis,et al.  Continuous spectrophotometric assay for retroviral proteases of HIV-1 and AMV. , 1989, Biochemical and biophysical research communications.

[29]  P. Štrop,et al.  Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease. , 1988, The Journal of biological chemistry.